Trump Signs Order on Psychedelics to Ease FDA Restrictions (1)

President Donald Trump signed an executive order to expedite research and access to psychedelics used outside the US to treat post-traumatic stress disorder.

“Today’s order will ensure that people suffering from debilitating symptoms might finally have a chance to reclaim their lives and lead a happier life,” Trump said in an Oval Office ceremony Saturday.

The order directs the US Food and Drug Administration to issue new guidance to researchers on ibogaine, a psychedelic compound extracted from the iboga plant in Africa that’s used to treat depression, anxiety and PTSD for military veterans. The hallucinogen is considered a Schedule I ...